Weight loss itself is associated with improved cognitive performance in multiple studies
Can a patient with Hashimotos thyroiditis safely be treated with a GLP1 receptor agonist (e.g., liraglutide, semaglutide, dulaglutide)?
Positive (peptidylprolyl isomerase B, NM_011149.2) and negative (Bacillus Subtillis, dihydropicolinate reductase, EF191515) in situ hybridization control probes were employed for assay validation in all analyses
Do not use frozen or cloudy semaglutide
In contrast, danuglipron-treated showed distinctly different kinetics, demonstrating that different compounds elicit distinct compartment-specific response signatures
The book wraps up by looking at the issue of weight and fat loss plateaus, how to distinguish between apparent and real plateaus along with a discussion of what causes them